Predictors of outcome after 6 and 12 months following anthroposophic therapy for adult outpatients with chronic disease: a secondary analysis from a prospective observational study

Table 5 Sensitivity analyses (SA): Summary of models

Analysis	N patients	Included variables	Adjusted R² 1^stvariable	Adjusted R² Full model	ANOVA P-Value
Main analysis	913	1,2,3,4,5,6,7,8,9	0.25	0.32	< 0.001
SA1: Patients with evaluable data for all variables	630	1,2,9,3,10,4,5,7,6	0.24	0.33	< 0.001
SA2: 75% random subsample	698	1,2,5,3,9,11,4	0.27	0.33	< 0.001
SA3: Remaining 25%, variables from SA2 model	213	1+2+5+3+9+11+4	Not applicable	0.32	< 0.001
SA4: Dependent variable Symptom Score 0-12 months	839	1,2,12,8,9,3,4,6	0.23	0.33	< 0.001
SA5: Dependent variable First Symptom 0-6 months	906	1*,2,9,3,8,7,11,4,5,13,12	0.23*	0.31	< 0.001

Included variables: Variable numbers from Table 4. *: Variable 1 = First ranked symptom at enrolment. Adjusted R²: Adjusted coefficient of multiple determination. ANOVA p-value: Analysis of variance with significance test for total model.

ISSN: 1756-0500